Skip to main content
Top
Published in: Dermatology and Therapy 2/2014

Open Access 01-12-2014 | Original Research

Topical, Non-Medicated LOYON® in Facilitating the Removal of Scaling in Infants and Children with Cradle Cap: a Proof-of-Concept Pilot Study

Author: Ulrich R. Hengge

Published in: Dermatology and Therapy | Issue 2/2014

Login to get access

Abstract

Introduction

Cradle cap is a very common condition in infants that presents as greasy, scaly patches on the scalp within the first weeks of life. Although usually disappearing by itself, the condition worries parents because of its appearance. When removing the scales, it is crucial to prevent spot bleedings to avoid infections. The investigational medical device LOYON® (Cetiol® CC, dimethicone) solution (G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, Germany) has the potential to meet these needs since it removes scales gently. It was, therefore, the aim of this proof-of-concept study to assess the efficacy and safety of topically applied, non-medicated LOYON® in facilitating the removal of scaling in infants and children with cradle cap without inducing spot bleedings.

Methods

This single-center, open, proof-of-concept, pilot study was conducted in 20 male or female infants/children aged 3–36 months with clinically diagnosed cradle cap. The 8-day study period included one to three applications of LOYON®. Clinical assessment of scaling and secondary parameters was performed at baseline and after treatment. Adverse events were recorded. A questionnaire on subjective efficacy and usability was handed out to the parents.

Results

With a maximum of three applications of LOYON® applied to 20 subjects, a reduction in scaling intensity from moderate or severe to very mild or mild was achieved in 80% of the subjects. Treatment success, defined as the reduction of the scaling baseline score by at least two points, was achieved in 50% of subjects. Results of this study do not indicate any safety concern. No spot bleedings were observed. LOYON® was generally well tolerated and overall treatment was rated as “good” by the parents/legal guardians.

Conclusion

This study suggests that LOYON® is well tolerated, safe and effective in facilitating the removal of scaling in infants and children with cradle cap. With its gentle approach and rapid effect, LOYON® thus represents a good alternative to home remedies for treatment of cradle cap.
Appendix
Available only for authorised users
Literature
1.
go back to reference Smoker AL. On top of cradle cap. J Fam Health Care. 2007;17(4):134–6.PubMed Smoker AL. On top of cradle cap. J Fam Health Care. 2007;17(4):134–6.PubMed
2.
go back to reference Steward M. Cradle cap. Community Outlook 1990;18. Steward M. Cradle cap. Community Outlook 1990;18.
3.
go back to reference Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003;139(3):318–22.PubMedCrossRef Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003;139(3):318–22.PubMedCrossRef
4.
go back to reference Johnson M-LT, Roberts J. Prevalence of dermatological disease among persons 1–74 years of age: United States. Advance data from Vital and Health Statistics National Center for Health Statistics; U S Department of Health, Education, and Welfare 1977;No 4:1–7. Johnson M-LT, Roberts J. Prevalence of dermatological disease among persons 1–74 years of age: United States. Advance data from Vital and Health Statistics National Center for Health Statistics; U S Department of Health, Education, and Welfare 1977;No 4:1–7.
5.
go back to reference Sachdeva M, Kaur S, Nagpal M, Dewan SP. Cutaneous lesions in new born. Indian J Dermatol Venereol Leprol. 2002;68(6):334–7.PubMed Sachdeva M, Kaur S, Nagpal M, Dewan SP. Cutaneous lesions in new born. Indian J Dermatol Venereol Leprol. 2002;68(6):334–7.PubMed
6.
go back to reference Janniger CK. Infantile seborrheic dermatitis: an approach to cradle cap. Cutis. 1993;51(4):233–5.PubMed Janniger CK. Infantile seborrheic dermatitis: an approach to cradle cap. Cutis. 1993;51(4):233–5.PubMed
7.
go back to reference O’Connor NR, McLaughlin MR, Ham P. Newborn skin: part I. Common rashes. Am Fam Phys. 2008;77(1):47–52. O’Connor NR, McLaughlin MR, Ham P. Newborn skin: part I. Common rashes. Am Fam Phys. 2008;77(1):47–52.
8.
go back to reference Elewski BE. Clinical diagnosis of common scalp disorders. J Investig Dermatol Symp Proc. 2005;10(3):190–3.PubMedCrossRef Elewski BE. Clinical diagnosis of common scalp disorders. J Investig Dermatol Symp Proc. 2005;10(3):190–3.PubMedCrossRef
9.
go back to reference McDonald LL, Smith ML. Diagnostic dilemmas in pediatric/adolescent dermatology: scaly scalp. J Pediatr Health Care. 1998;12(2):80–4.PubMedCrossRef McDonald LL, Smith ML. Diagnostic dilemmas in pediatric/adolescent dermatology: scaly scalp. J Pediatr Health Care. 1998;12(2):80–4.PubMedCrossRef
10.
go back to reference Singleton JK. Pediatric dermatoses: three common skin disruptions in infancy. Nurse Pract. 1997;22(6):32–51.PubMedCrossRef Singleton JK. Pediatric dermatoses: three common skin disruptions in infancy. Nurse Pract. 1997;22(6):32–51.PubMedCrossRef
11.
go back to reference Arora V, Arora S. Management of infantile seborrheic dermatitis. Am Fam Physician. 2007;75(6):807.PubMed Arora V, Arora S. Management of infantile seborrheic dermatitis. Am Fam Physician. 2007;75(6):807.PubMed
12.
go back to reference Fleischer AB Jr. Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Clin Pediatr (Phila). 2008;47(4):332–46.CrossRef Fleischer AB Jr. Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Clin Pediatr (Phila). 2008;47(4):332–46.CrossRef
13.
go back to reference Morrell DS, Burkhart CN, Poindexter GB. Therapies for pediatric seborrheic dermatitis. Pediatr Ann. 2009;38(6):333–8.PubMedCrossRef Morrell DS, Burkhart CN, Poindexter GB. Therapies for pediatric seborrheic dermatitis. Pediatr Ann. 2009;38(6):333–8.PubMedCrossRef
14.
go back to reference Zuniga R, Nguyen T. Skin conditions: common skin rashes in infants. FP Essent. 2013;407:31–41.PubMed Zuniga R, Nguyen T. Skin conditions: common skin rashes in infants. FP Essent. 2013;407:31–41.PubMed
15.
go back to reference Sheffield RC, Crawford P, Wright ST, King VJ. Clinical inquiries. What’s the best treatment for cradle cap? J Fam Pract. 2007;56(3):232–3.PubMed Sheffield RC, Crawford P, Wright ST, King VJ. Clinical inquiries. What’s the best treatment for cradle cap? J Fam Pract. 2007;56(3):232–3.PubMed
16.
go back to reference Shohat M, Mimouni M, Shuper A, Varsano I. Adrenocortical suppression by topical application of glucocorticosteroids in infants with seborrheic dermatitis. Clin Pediatr (Phila). 1986;25(4):209–12.CrossRef Shohat M, Mimouni M, Shuper A, Varsano I. Adrenocortical suppression by topical application of glucocorticosteroids in infants with seborrheic dermatitis. Clin Pediatr (Phila). 1986;25(4):209–12.CrossRef
17.
go back to reference Turpeinen M, Lehtokoski-Lehtiniemi E, Leisti S, Salo OP. Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children. Pediatr Dermatol. 1988;5(4):276–9.PubMedCrossRef Turpeinen M, Lehtokoski-Lehtiniemi E, Leisti S, Salo OP. Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children. Pediatr Dermatol. 1988;5(4):276–9.PubMedCrossRef
18.
go back to reference Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol. 2013;30(1):42–50.PubMedCrossRef Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol. 2013;30(1):42–50.PubMedCrossRef
19.
go back to reference Siegfried E, Glenn E. Use of olive oil for the treatment of seborrheic dermatitis in children. Arch Pediatr Adolesc Med. 2012;166(10):967.PubMedCrossRef Siegfried E, Glenn E. Use of olive oil for the treatment of seborrheic dermatitis in children. Arch Pediatr Adolesc Med. 2012;166(10):967.PubMedCrossRef
20.
go back to reference Williams C. Olive oil for cradle cap? Community Pract. 2010;83(11):14.PubMed Williams C. Olive oil for cradle cap? Community Pract. 2010;83(11):14.PubMed
21.
go back to reference Hill K. Industrial development and application of biobased oleochemicals. Pure Appl Chem. 2007;79(11):1999–2011.CrossRef Hill K. Industrial development and application of biobased oleochemicals. Pure Appl Chem. 2007;79(11):1999–2011.CrossRef
22.
go back to reference Nolan K, Marmur E. Moisturizers: reality and the skin benefits. Dermatol Ther. 2012;25(3):229–33.PubMedCrossRef Nolan K, Marmur E. Moisturizers: reality and the skin benefits. Dermatol Ther. 2012;25(3):229–33.PubMedCrossRef
Metadata
Title
Topical, Non-Medicated LOYON® in Facilitating the Removal of Scaling in Infants and Children with Cradle Cap: a Proof-of-Concept Pilot Study
Author
Ulrich R. Hengge
Publication date
01-12-2014
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2014
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-014-0060-3

Other articles of this Issue 2/2014

Dermatology and Therapy 2/2014 Go to the issue